Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A young patient with visual disturbance.
Myelination, oligodendrocytes, and serious mental illness.
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
[Evolution of Devic's neuromyelitis optica spectrum disorders.]
Neuronal activity biases axon selection for myelination in vivo.
Upregulation of immunomodulatory molecules by Matrine treatment in experimental autoimmune encephalomyelitis.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
Participation as an Outcome in Multiple Sclerosis Falls-Prevention Research: Consensus Recommendation from the International MS Falls Prevention Research Network.
Demographic and clinical profile of myelopathy patients.
Inhibitory saccadic dysfunction is associated with cerebellar injury in multiple sclerosis.
Antigen-specific tolerization approaches in multiple sclerosis.
Acute autonomic, sensory and motor neuropathy associated with meningoencephalitis.
[Illness, health and sunlight].
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
The new era of multiple sclerosis therapy.
Decrease of mutual information in brain electrical activity of patients with relapsing-remitting multiple sclerosis.
Bone marrow derived elements and resident microglia in brain inflammation.
Pages
« first
‹ previous
…
535
536
537
538
539
540
541
542
543
…
next ›
last »